Ident. | Authors (with country if any) | Title |
---|
002310 (2001) |
| Subject index |
002312 (2001) |
| Subject Index |
002315 (2001) |
Leonie Harmse [Afrique du Sud] ; Robyn Van Zyl [Afrique du Sud] ; Nathanael Gray [États-Unis] ; Peter Schultz [États-Unis] ; Sophie Leclerc [France] ; Laurent Meijer [France] ; Christian Doerig [France] ; Ivan Havlik [Afrique du Sud] | Structure-activity relationships and inhibitory effects of various purine derivatives on the in vitro growth of Plasmodium falciparum |
002490 (2000) |
Marko Vezmar [Canada] ; Elias Georges [Canada] | Reversal of MRP-mediated doxorubicin resistance with quinoline-based drugs |
002663 (1999) |
| Index |
002675 (1999) |
Rachida Legssyer [Belgique] ; Roberta J. Ward [Belgique] ; Robert R. Crichton [Belgique] ; Johan R. Boelaert [Belgique] | Effect of chronic chloroquine administration on iron loading in the liver and reticuloendothelial system and on oxidative responses by the alveolar macrophages |
002816 (1998) |
Géraldine Pron [France] ; Nawel Mahrour [France] ; Stéphane Orlowski [France] ; Omar Tounekti [France] ; Bruno Poddevin [France] ; Jean Belehradek [France] ; Lluis M. Mir [France] | Internalisation of the bleomycin molecules responsible for bleomycin toxicity: a receptor-mediated endocytosis mechanism |
002818 (1998) |
| Index |
002827 (1998) |
Marko Vezmar [Canada] ; Elias Georges [Canada] | Direct binding of chloroquine to the multidrug resistance protein (MRP) |
002906 (1997) |
Morten Sorensen [Danemark] ; Maxwell Sehested [Danemark] ; Peter Buhl Jensen [Danemark] | pH-Dependent regulation of camptothecin-induced cytotoxicity and cleavable complex formation by the antimalarial agent chloroquine |
002948 (1997) |
Peter Buhl Jenen [Danemark] ; Maxwell Sehested [Danemark] | DNA topoisomerase II rescue by catalytic inhibitors |
002A34 (1996) |
Maxwell Sehested [Danemark] ; Peter Buhl Jensen [Danemark] | Mapping of DNA topoisomerase II poisons (etoposide, clerocidin) and catalytic inhibitors (aclarubicin, ICRF-187) to four distinct steps in the topoisomerase II catalytic cycle |
002A43 (1996) |
Franco Dosio [Italie] ; Antonia Franceschi [Italie] ; Maurizio Ceruti [Italie] ; Paola Brusa [Italie] ; Luigi Cattel [Italie] ; Marco Colombatti [Italie] | Enhancement of ricin toxin a chain immunotoxin activity: Synthesis, ionophoretic ability, and in vitro activity of monensin derivatives |
002B30 (1995) |
Ulrich E. Honegger [Suisse] ; Isabel Scuntaro [Suisse] ; Ulrich N. Wiesmann [Suisse] | Vitamin E reduces accumulation of amiodarone and desethylamiodarone and inhibits phospholipidosis in cultured human cells |
002B50 (1995) |
James F. Eliason [Japon] ; Henri Ramuz [Suisse] ; Takashi Yoshikubo [Japon] ; Tohru Ishikawa [Japon] ; Taeko Yamamoto [Japon] ; Takashi Tsuruo [Japon] | Novel dithiane analogues of tiapamil with high activity to overcome multidrug resistance in vitro |
002C69 (1994) |
Patricia J. Evans [Royaume-Uni] ; Dola Akanmu [Royaume-Uni] ; Barry Halliwell [Royaume-Uni] | Promotion of oxidative damage to arachidonic acid and α 1-antiproteinase by anti-inflammatory drugs in the presence of the haem proteins myoglobin and cytochrome C |
002D57 (1993) |
| Biochemical pharmacology subject index for volume 45, 1993 |
002D65 (1993) |
Annette Kragh Larsen [France] ; Lucile Grondard [France] ; Jeannine Couprie ; Bernard Desoize ; Leopold Comoe ; Jean-Claude Jardillier ; Jean-François Riou [France] | The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and II |
002E05 (1993) |
Ulrich E. Honegger [Suisse] ; Roger D. Zuehlke [Suisse] ; Isabel Scuntaro [Suisse] ; Markus H. A. Schaefer [Suisse] ; Hermann Toplak [Suisse] ; Ulrich N. Wiesmann [Suisse] | Cellular accumulation of amiodarone and desethylamiodarone in cultured human cells |
002E52 (1992) |
Igor B. Roninson [États-Unis] | The role of the MDR 1 (p-glycoprotein) gene in multidrug resistance in vitro and in vivo |
002E53 (1992) |
Anthony C. Harrison [Royaume-Uni] ; Neil R. Kitteringham [Royaume-Uni] ; Janet B. Clarke [Royaume-Uni] ; B. Kevin Park [Royaume-Uni] | The mechanism of bioactivation and antigen formation of amodiaquine in the rat |
002F08 (1991) |
| Subject index for volume 41, 1991 |
002F79 (1991) |
Karl Y. Hostetler [États-Unis] ; Jerry Vande Berg [États-Unis] ; Kathy A. Aldern [États-Unis] ; Gregory T. Brophy [États-Unis] | Effect of amiodarone on the phospholipid and lamellar body content of lymphoblasts in vitro and peripheral blood lymphocytes in vivo |
003052 (1990) |
Christian P. L. Lewis [Royaume-Uni] ; Gerald M. Cohen [Royaume-Uni] ; Lewis L. Smith [Royaume-Uni] | The identification and characterization of an uptake system for taurine into rat lung slices |
003156 (1989) |
Gautam Chaudhuri [Inde] ; Amitabha Mukhopadhyay [Inde] ; Sandip K. Basu [Inde] | Selective delivery of drugs to macrophages through a highly specific receptor |
003181 (1989) |
Okezie I. Aruoma [Royaume-Uni] ; Barry Halliwell [Royaume-Uni] ; John Butler [Royaume-Uni] ; Brigid M. Hoey [Royaume-Uni] | Apparent inactivation of α1-antiroteinase by sulphur-containing radicals derived from penicillamine |
003233 (1988) |
Maxwell Sehested [Danemark] ; Torben Skovsgaard [Danemark] ; Henrik Roed [Danemark] | The carboxylic ionophore monensin inhibits active drug efflux and modulates in vitro resistance in daunorubicin resistant Ehrlich ascites tumor cells |
003330 (1987) |
Christine Waterkeyn [Belgique] ; Pierre Laduron [Belgique, France] ; Willem Meuldermans [Belgique] ; Andre Trouet [Belgique] ; Yves-Jacques Schneider [Belgique] | Uptake, subcellular distribution and biotransformation of 3H-labelled astemizole in cultured rat hepatocytes |
003349 (1987) |
Stanley J. Szefler [États-Unis] ; Carl K. Edwards Iii [États-Unis] ; Christopher Haslett [États-Unis] ; Nancy R. Zahniser [États-Unis] ; Jerry A. Miller [États-Unis] ; Peter M. Henson [États-Unis] | Effects of cell isolation procedures and radioligand selection on the characterization of human leukocyte β-adrenergic receptors |
003416 (1986) |
Gordon Cramb [Royaume-Uni] | Selective lysosomal uptake and accumulation of the beta-adrenergic antagonist propranolol in cultured and isolated cell systems |
003443 (1986) |
Donald J. Krogstad [États-Unis] ; Paul H. Schlesinger [États-Unis] | A perspective on antimalarial action: Effects of weak bases on Plasmodium falciparum |
003648 (1983) |
Guido V. Marinetti [États-Unis] ; Stephen I. Rosenfeld [États-Unis] ; Patricia A. Thiem [États-Unis] ; John J. Condemi [États-Unis] ; John P. Leddy [États-Unis] | beta-adrenergic receptors of human leukocytes |
003798 (1981) |
Anuradha S. Pappu [États-Unis] ; George Hauser [États-Unis] | Changes in brain polyphosphoinositide metabolism induced by cationic amphiphilic drugs in vitro |
003842 (1980) |
I. Ahnfelt-R Nne [Danemark] ; E. Arrigoni-Martelli [Danemark] | A new antiinflammatory compound, timegadine ( N -cyclohexyl- N ′′-p-methylquinolyl N ′-Z-thiazolylguanidine), which inhibits both prostaglandin and 12-hydroxyeicosatetraenoic acid (12-HETE) formation |
003887 (1979) |
Rodney F. Minchin ; Kenneth F. Ilett ; Barry W. Madsen | Chlorphentermine binding in rat lung subcellular fractions and its displacement by desmethylimipramine |
003927 (1978) |
Heinz Lüllmann [Allemagne] ; Renate Lüllmann-Rauch [Allemagne] ; Otmar Wassermann [Allemagne] | Lipidosis induced by amphiphilic cationic drugs |
003998 (1976) |
Wang Chih-Cheng [États-Unis] ; Suzanne Straight [États-Unis] ; Donald L. Hill [États-Unis] | Destabilization of mouse liver lysosomes by vitamin a compounds and analogues |
003A64 (1974) |
David L. Roerig [États-Unis] ; Andrew T. Hasegawa [États-Unis] ; Richard E. Peterson [États-Unis] ; Richard I. H. Wang [États-Unis] | Effect of chloroquine and phenobarbital on morphine glucuronidation and biliary excretion in the rat |
003D00 (1967) |
K. R. Bailey [États-Unis] ; A. L. Sheffner [États-Unis] | The reduction of experimentally induced inflammation by sulfhydryl compounds |
003D04 (1967) |
Evan W. Mcchesney [États-Unis] ; James M. Shekosky [États-Unis] ; Patrick H. Hernandez [États-Unis] | Metabolism of chloroquine-3-14C in the rhesus monkey |